Literature DB >> 1389523

The EORTC trials for limited stage Hodgkin's disease. The EORTC Lymphoma Cooperative Group.

J M Cosset1, M Henry-Amar, J H Meerwaldt, P Carde, E M Noordijk, J Thomas, J M Burgers, R Somers, M Hayat, M Tubiana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1389523     DOI： 10.1016/0959-8049(92)90018-w

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  8 in total

1.  SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.

Authors:  Cristina Quero Blanco; Ramón García Arroyo; Mariano Provencio Pulla; Antonio Rueda Domínguez; Dolores Isla Casado
Journal:  Clin Transl Oncol       Date:  2010-11       Impact factor: 3.405

Review 2.  ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II.

Authors:  Sughosh Dhakal; Ranjana Advani; Leslie K Ballas; Bouthaina S Dabaja; Christopher R Flowers; Chul S Ha; Bradford S Hoppe; Nancy P Mendenhall; Monika L Metzger; John P Plastaras; Kenneth B Roberts; Ronald Shapiro; Sonali M Smith; Stephanie A Terezakis; Karen M Winkfield; Anas Younes; Louis S Constine
Journal:  Am J Clin Oncol       Date:  2016-12       Impact factor: 2.339

Review 3.  [Pathogenesis and therapy of Hodgkin lymphoma].

Authors:  H Tesch; H Bohlen; J Wolf; A Engert
Journal:  Med Klin (Munich)       Date:  1998-02-15

Review 4.  Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk.

Authors:  J G Franklin; M D Paus; A Pluetschow; L Specht
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

5.  SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.

Authors:  A Rueda Domínguez; J Alfaro Lizaso; L de la Cruz Merino; J Gumá I Padró; C Quero Blanco; J Gómez Codina; M Llanos Muñoz; N Martinez Banaclocha; D Rodriguez Abreu; M Provencio Pulla
Journal:  Clin Transl Oncol       Date:  2015-10-26       Impact factor: 3.405

6.  Chemotherapy alone or combined chemotherapy and involved field radiotherapy in favorable risk early-stage classical Hodgkin lymphoma-a 10 years experience.

Authors:  Sheeraz Ali; Abdul Basit; Ather S Kazmi; Armughan Sidhu; Farhana Badar; Abdul Hameed
Journal:  Pak J Med Sci       Date:  2016 Nov-Dec       Impact factor: 1.088

7.  Assessment of the Neutrophil-Lymphocyte Ratio in Classic Hodgkin Lymphoma Patients.

Authors:  Ali Dogan; Sinan Demircioglu
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

Review 8.  Isolated hypoglossal nerve palsy as a presenting symptom of metastatic peripheral T-cell lymphoma - not otherwise specified (PTCL-NOS): a unique case & a review of the literature.

Authors:  Emily Bryer; David Henry
Journal:  Int J Hematol Oncol       Date:  2018-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.